Dr. Vicky Tagalakis
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots (NCT02752607) | Dr. Vicky Tagalakis | 2016-05-01 |
Track Dr. Vicky Tagalakis automatically
Every clearance here is in the API, with alerts when new ones post.